METASTATIC PANCREATIC CARCINOMA
Clinical trials for METASTATIC PANCREATIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests two experimental drugs, ZEN003694 and entinostat, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors. The trial includes up to 49 participants,…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:17 UTC
-
New hope for pancreatic cancer: targeted pill study goes fully remote
Disease control Recruiting nowThis study tests a drug called pemigatinib in 40 adults with advanced or metastatic pancreatic cancer that has certain changes in the FGFR gene. The drug aims to block these abnormal genes and stop tumor growth. The study is done entirely through telemedicine, so participants can…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New hope for advanced cancers with DNA repair flaws: PARP inhibitor trial opens
Disease control Recruiting nowThis study tests the drug talazoparib in adults with advanced solid tumors (like breast, prostate, ovarian, pancreatic, or stomach cancer) that have certain gene changes affecting DNA repair. The drug blocks a protein called PARP, which cancer cells need to fix their DNA, potenti…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Heated chemotherapy attack on pancreatic cancer spread shows promise in new trial
Disease control Recruiting nowThis study is for people with pancreatic cancer that has spread to the lining of the abdomen. Doctors are testing a treatment called HIPEC, where heated chemotherapy drugs are placed directly into the belly during surgery. The goal is to see if this approach can help people live …
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New hope for hard-to-treat pancreatic cancer: targeted combo enters trial
Disease control Recruiting nowThis study tests a new drug combination (HRS-4642, nimotuzumab, and chemotherapy) as a first treatment for advanced pancreatic cancer that has spread. It is for people whose tumors have a specific KRAS G12D mutation. The goal is to see if the combo shrinks tumors or controls the …
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Scientists use special microscope to peek inside tumors during surgery
Knowledge-focused Recruiting nowThis study uses a special microscope called intravital microscopy (IVM) to watch blood vessels inside solid tumors in real time during surgery. Researchers want to understand how these vessels work, which could help decide if a patient's tumor is likely to respond to certain trea…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC